Related Experiment Video
Updated: Jan 16, 2026

07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
4.2K
Robotic partial nephrectomy for complex renal masses: technical approach and perioperative outcomes
Poulomi Dey1, Shresth Manglik2, Forqan Babu Shaikh3
1Department of General and Minimal Invasive Surgery, Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, India.
Journal of Robotic Surgery
|October 3, 2025
Summary
Robotic-assisted partial nephrectomy (RAPN) provides excellent outcomes for complex kidney tumors, even during a center's learning curve. This study validates the technique's reproducibility and safety for challenging renal masses.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Robotic-assisted partial nephrectomy (RAPN) offers technical benefits for complex renal masses.
- Outcome data from new centers performing RAPN are limited.
- Validation of RAPN for complex cases is crucial for broader adoption.
Purpose of the Study:
- To detail the RAPN technique for complex renal tumors.
- To evaluate perioperative outcomes during the initial experience at an emerging center.
- To assess the feasibility and safety of RAPN for challenging kidney cancers.
Main Methods:
- Prospective analysis of 35 consecutive RAPN procedures using a five-port transperitoneal approach.
- Inclusion of complex cases: endophytic, centrally located, or collecting system-proximal tumors.
- Data collection included operative parameters, complications, and functional preservation.
Main Results:
- Mean tumor size 4.01 cm; mean RENAL score 6.4, with 54.3% endophytic.
- Mean operative time 198.5 min, console time 143.0 min, warm ischemia 29.2 min.
- Zero positive margins, minimal creatinine increase (0.13 mg/dL), and 82.9% trifecta achievement.
Conclusions:
- The described RAPN technique yields excellent perioperative outcomes for complex renal masses.
- Reproducible results were achieved during the learning curve at an emerging center.
- RAPN is a safe and effective option for challenging kidney tumors, supporting its use in new institutions.

